ABSTRACT. To characterize the erythrocyte insulin receptor in newborn infants we studied the binding of lZ51-insulin to the erythrocytes from 42 preterm infants (14 at birth, 14 aged 2-7 days, and 14 aged 8-16 days) with a mean gestational age of 34.1 wk, and from 32 term infants (16 at birth and 16 aged 2-7 days). The insulin binding to cord blood erythrocytes from preterm infants was significantly higher than that of cord blood cells from term infants and to postnatal cells from preterm as well as term infants. The erythrocytes from preterm infants aged 2-7 days bound more insulin than cells from preterm infants aged 8-16 days. The maximum insulin binding (specific insulin binding at tracer concentration of insulin) correlated negatively with the gestational age both at birth and over the 1st postnatal wk. In the preterm infants there was a strong negative correlation between the maximum insulin binding and postnatal age. The enhanced insulin binding to cord blood erythrocytes from preterm infants was due to both an increased receptor concentration and a high affinity for insulin. The increased affinity persisted over the 1st wk of life. In preterm infants older than 1 wk the insulin binding characteristics were basically similar to those in term newborn infants. In all infants studied the receptor concentration seemed to be postnatal age dependent while the receptor affinity was gestational age dependent. No correlation was found between the insulin binding data and the sions must be made with caution. In addition, discrepancies between insulin binding to monocytes and erythrocytes are known, for instance important differences have been shown in the way that their receptors are regulated (2, 3) . The erythrocytes are the cells of choice for studies on insulin receptor in infants and small children, since small sample volumes are required. However, the effect of some physiological variables, such as age, cell age and gestational age on the erythrocyte insulin binding must be taken into account in these studies, otherwise the evaluations may result in misleading interpretations (4) (5) (6) (7) . We have previously demonstrated that insulin binding to erythrocytes is correlated to chronological age, being highest in cord blood erythrocytes (7) . Cord blood erythrocytes from preterm infants have been found to bind even more insulin than those from term infants and, in addition, there is a strong negative correlation between the insulin binding to cord blood erythrocytes and gestational age (4, 6) . The increased erythrocyte insulin binding in term infants at birth persists over the neonatal period and the major decrease in insulin binding occurs during the 1st yr of life (7) . In the present study we have examined erythrocyte insulin binding in preterm infants over the first weeks of life in order to evaluate postnatal changes in the characteristics of their erythrocyte insulin receptor.
MATERIALS AND METHODS
plasma concentrations of immunoreactive insulin or CSubjects, We studied 14 preterm (group and 16 infants peptide. The growth stirnulatory effect insulin in (group 4) at birth, 14 preterm (group 2) and 16 term infants life may be mediated by increased insulin binding to fetal (group 5) aged 2-7 days as well as 14 preterm infants (group 3) cells, since preterm infants at birth have a high erythrocyte older than wk, The clinical data of the subjects are presented insulin binding capacity which decreases with increasing in Table  The birth weight ratio was calculated as the ratio gestational age. The down-regu1ation of the between the actual birth weight and the 50th percentile weight in preterm infants may reflect for that gestational age (8) . ~l u c o c o~i c o i d treatment was given the changing role of insulin from an intrauterine growth to two mothers in group to one in group 2, and to two in stimulating peptide to a hormone mainly regulating post-group 3 prior to delivery. Ritadrine was infused to six mothers natal carbohydrate metabolism. (Pediatr Res 20: 256-260, in group to five in group 2, and to three in group during 1986) premature labor. The neonatal course was complicated by a mild or moderate respiratory distress syndrome in two infants in group Abbreviations 1, in two in group 2, and in one in group 3. One baby in each IRI, immunoreactive insulin group of preterm infants was treated with teophyllamine due to &, empty site affinity recurrent attacks of apnea. Hyperbilirubinemia necessitating Ka full site affinity phototherapy was seen in five infants in group 1, in three in groups 2, 3, and 4, respectively, and in five in group 5. One infant in group 1 and 2, respectively, was treated with exchange transfusion, which was, however, performed after the time of In general, alterations in the properties of human insulin sampling. Neonatal hypoglycemia was not diagnosed in any of receptor in normal conditions as well as during disease have been the infants studied. The data on the term infants have been measured in receptor-bearing cells that are readily accessible, published previously (7). Informed consent was obtained from such as circulating monocytes and erythrocytes. The receptors the parents of the subjects. The gestational age of the infants was on these cells generally reflect the status of receptors on the major estimated from the menstrual history of the mother and from target organs, although exceptions are known (I), and conclu-examination of the baby using the criteria of Dubowitz et al. (9 Methods. The blood samples (10-15 ml) were collected into cooled heparinized tubes. Plasma was frozen for later analysis of IRI and C-peptide.
For the determination of m~n o -'~~I (Tyr A14) insulin (0.25 ng/ml, specific activity 200-250 pCi/pg, NOVO Research Institute, Bagsvaerd, Denmark) binding to erythrocytes the method of Gambhir et al. (10) was used with a few modifications (7). Specific insulin binding was defined as a total minus nonspecific binding, the latter determined by obtaining the values in the presence of lo5 ng/ml unlabeled insulin. The amount of insulin specifically bound was corrected to a final erythrocyte concentration of 3.52 x lo9 cells/ml. The nonspecific binding was about 10-16% of the total binding (1.9-2.5% of the total radioactivity). Binding data were analyzed by Scatchard plot and the average affinity profile was determined by the method of DeMeyts and Roth (1 I), in which the highest insulin concentration used for calculations was 100 ng/ml.
The blood glucose concentrations were measured by the hexokinase method (Boehringer Mannheim, Mannheim, FRG). Plasma IRI concentrations were measured radioimmunologically using antiserum M 8309 (Novo Research Institute) with a minor modification of the charcoal separation method described by Herbert et al. (12) . Plasma C-peptide concentrations were determined according to Heding (13) using antiserum M 1230 (Novo Research Institute).
Statistical analyses. The statistical evaluation was performed using linear regression analysis and parametric one-way analysis of variance. A modified t test [Bonferroni (14) ] was used for comparisons between two groups.
RESULTS
The insulin binding to cord blood erythrocytes from preterm infants was significantly higher at tracer and physiological insulin concentrations ( p < 0.0 1 or less) than was binding to cord blood cells from term infants or to postnatal cells from preterm as well as term infants (Fig. 1, Table 2 ). Although the insulin binding to the erythrocytes from preterm infants aged 2-7 days was not significantly higher than that from term infants of similar age ( p < 0. l), it further decreased significantly ( p < 0.05 or less) during the 2nd wk of life in preterm infants to a level that was slightly lower than that found in term infants aged 2-7 days. Ritadrine infusion to the mother during premature labor had no effect on the insulin binding at tracer concentration. The maximum insulin binding to cord blood erythrocytes as well as to those from newborn infants aged 2-7 days decreased with increasing gestational age (Fig. 2 A and B) . In all preterm infants there was a strong negative correlation between maximum insulin binding and postnatal age (Fig. 3) . In all subjects studied there was also a negative correlation between maximum insulin binding and gestational age (r = -0.33, p < 0.01) as well as the postnatal age ( r = -0.46, p < 0.001). Furthermore, there was a positive correlation between the maximum insulin binding and the reticulocyte count ( r = 0.33, p < 0.01) in all subjects studied, but no such correlation was found in the combined cord blood group or the combined group of newborn infants younger than 1 wk. The mean reticulocyte counts in cord blood erythrocytes (preterm: 2.3% and term: 2.1 %) were significantly higher ( p < 0.0 1 or less) than that found in postnatal erythrocytes (less than 1.1 %). We found no correlation between the maximum insulin binding and the birth weight ratio or the postnatal weight loss. Neither was there any correlation between the maximum insulin binding and the contemporaneous blood glucose concentration or the lowest blood glucose level observed in the neonatal period.
The Scatchard analysis of the insulin binding data in the preterm infants is shown in Figure 4 , and the number of binding sites per cell as well as the average affinity constants for empty and full sites in the preterm and term infants in Table 2 The blood glucose concentrations and plasma levels of IRI and C-peptide of the infants were also measured (Table 3 ). There were no significant differences in the concentrations of blood glucose, plasma IRI, or C-peptide between the different groups 
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of preterm and term infants and no significant correlations between the insulin binding data and the circulating concentrations of IRI or C-peptide. 
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The present results show that the considerably increased erythrocyte insulin binding in preterm infants at birth decreases over the first 2 wk of life to a level similar to that seen in term newborn infants. Previous studies have shown that cord blood erythrocytes from preterm infants have both an increased receptor concentration and an increased affinity for insulin when compared to erythrocytes from adults (6, lo) , whereas cord blood cells from term infants are characterized by an increased receptor concentration only (7) . Our observations indicate that the decrease in erythrocyte insulin binding seen in preterm newborn infants over the 1st wk of life is completely due to a substantial loss of binding sites, while the subsequent decline results from a reduced receptor affinity for insulin.
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The drastic hematological changes which occur in the neonatal 9 period (15) could be one explanation for the postnatal changes observed in the erythrocyte insulin receptors in preterm infants. The rate of production of red cells decreases dramatically during
. . * the first few days after birth, which diminishes the proportion of young cells and reticulocytes. This provides, at least partly, an explanation for the rapid postnatal decrease in receptor number observed both in preterm and term infant, since immature their receptor affinity for insulin after birth, whereas the postnatal decrease in the receptor concentration is at least partly a consequence of hematological changes. The differences in receptor affinity must be due to factors other than cell maturity, since the presence of young cells does not affect the affinity (5) . In erythrocytes from term infants most of the changes in the insulin receptor characteristics have already occurred prenatally.
In the fetus insulin is mainly needed for the regulation of growth (17) , whereas the function of insulin alters after birth, when insulin also starts participating in the control of circulating blood glucose levels. Provided that the insulin binding to fetal erythrocytes mirrors binding characteristics of insulin receptors on actual target cells of insulin, the conspicuously high insulin binding to erythrocytes from preterm infants at birth emphasizes the crucial role of insulin in the regulation of fetal growth and offers a possible mechanism by which the growth stimulatory effect of insulin may be mediated. This hypothesis is supported by the decrease over the last trimester in insulin binding to fetal erythrocytes, as shown in the present study, and the concomitant decrease in fetal growth velocity, as previously observed (18) . In ' rocytes (5, 16) . Although the life span of erythrocytes in preterm l6 infants is very short, 30-50 days (15) , the changes in the char-
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acteristics of the insulin receptors occur more rapidly than the insulin after birth. Obviously the erythrocytes from preterrn infants modulate their insulin binding chiefly by alterations in preterm infants without severe neonatal disease the postnatal growth proceeds more rapidly than in term newborn infants, but not as fast as in the intrauterine period (19) . The changes in insulin binding occurring over the first weeks of life in preterm infants fit well with such a growth pattern. Preterm infants have an increased risk of developing hypoglycemia in the early neonatal period (20) . The increased insulin binding in preterm infants at birth may contribute to the tendency to low blood glucose concentrations during the first few days of life, whereas a rapid postnatal decrease in insulin binding could protect the preterm infant from hypoglycemia later on. Since the insulin binding to cord blood erythrocytes as well as to those from newborn infants decreased with increasing gestational age and was also correlated to postnatal age, it is essential to use controls matched for both gestational and chronological age in studies on erythrocyte insulin binding in the neonatal period. The receptor concentration seems to be age dependent, while the affinity for insulin seems to be gestational age dependent in newborn infants. As indicated previously (7), age-matched controls are also necessary throughout childhood.
